December 2023 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2023-12-29, 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of December 2023

100

Ranked drops

-88.99%

Largest, GDHG

98.0%

Below baseline, day +5

9.8%

Median deeper below baseline, day +5

Filter and sort

100 ranked drops in December 2023

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	GDHG release reads positive	-88.99%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership Release reads positive, stock fell 88.99%	Golden Heaven Group Holdings Ltd. Intends to Enter into an Operating Lease Framework Agreement with a Top-tier Chinese Amusement Group 12/06/2023 20:00 ET after hours	Day +1 -93.55% 2023-12-08 Day +5 -93.55% 2023-12-14 Best recovery within 5 -93.03% 2023-12-12 Five sessions later the drop was 5.1% bigger, at -93.55%. Month end -96.54% on 2023-12-29
Close before and after $395,250.00 to $43,500.00 split-adjusted Session open, high, low $391,500.00, $418,125.00, $41,250.00 Opening gap -0.95% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 468 shares, $20,358,000 Relative volume 24.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
2	RPHM under $25M today	-82.71%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) 12/14/2023 09:05 ET premarket	Day +1 -81.68% 2023-12-15 Day +5 -82.45% 2023-12-21 Best recovery within 5 -81.16% 2023-12-19 0.3% of the drop was recovered five sessions later. Month end -79.35% on 2023-12-29
Close before and after $77.50 to $13.40 as traded Session open, high, low $12.60, $16.70, $9.80 Opening gap -83.74% Close inside the session range 0.52 of the range, where 1.00 is the high Session volume 2,634,161 shares, $35,297,757 Relative volume 124.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
3	TRKA More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-71.85%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Troika Media Group Inc. Announces Strategic Chapter 11 Filing and Sale to Blue Torch 12/07/2023 03:00 ET premarket	Day +1 -82.41% 2023-12-08 Day +5 -88.22% 2023-12-14 Best recovery within 5 -82.41% 2023-12-08 Five sessions later the drop was 22.8% bigger, at -88.22%. Month end -94.63% on 2023-12-29
Close before and after $1.91 to $0.5376 as traded Session open, high, low $0.3935, $0.7800, $0.3819 Opening gap -79.40% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 16,989,237 shares, $9,133,414 Relative volume 55.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	EBIX	-67.55%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Ebix Reaches "Stalking Horse" Sale Agreement for Life Insurance and Annuity Business with Zinnia to Ensure Successful Recapitalization Efforts 12/18/2023 06:03 ET premarket	Day +1 -57.91% 2023-12-19 Day +5 -65.31% 2023-12-26 Best recovery within 5 -57.91% 2023-12-19 3.3% of the drop was recovered five sessions later. Month end -78.90% on 2023-12-29
Close before and after $4.93 to $1.60 as traded Session open, high, low $2.47, $3.27, $1.34 Opening gap -49.90% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 21,641,938 shares, $34,627,101 Relative volume 16.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
5	ALVR	-67.15%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy 12/22/2023 07:00 ET premarket	Day +1 -67.78% 2023-12-26 Day +5 -70.46% 2024-01-02 Best recovery within 5 -67.78% 2023-12-26 Five sessions later the drop was 4.9% bigger, at -70.46%. Month end -70.82% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $53.59 to $17.60 as traded Session open, high, low $17.51, $18.75, $17.25 Opening gap -67.32% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 1,161,449 shares, $20,446,380 Relative volume 30.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	AADI	-56.42%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations 12/14/2023 16:05 ET after hours	Day +1 -58.29% 2023-12-18 Day +5 -63.31% 2023-12-22 Best recovery within 5 -58.29% 2023-12-18 Five sessions later the drop was 12.2% bigger, at -63.31%. Month end -62.38% on 2023-12-29
Close before and after $5.37 to $2.34 as traded Session open, high, low $2.34, $2.71, $2.25 Opening gap -56.42% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 6,035,849 shares, $14,123,887 Relative volume 58.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	MYND under $25M today release reads positive	-56.32%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition Release reads positive, stock fell 56.32%	Mynd.ai, Inc. Consummates Merger Transaction 12/13/2023 07:00 ET premarket	Day +1 -69.85% 2023-12-14 Day +5 -68.41% 2023-12-20 Best recovery within 5 -65.50% 2023-12-15 Five sessions later the drop was 21.5% bigger, at -68.41%. Month end -58.13% on 2023-12-29
Close before and after $13.23 to $5.78 split-adjusted Session open, high, low $8.54, $9.64, $5.35 Opening gap -35.46% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 41,356 shares, $239,038 Relative volume 39.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	UCAR under $25M today	-55.59%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	U Power Limited Announces Pricing of Registered Follow-on Offering 12/04/2023 09:00 ET premarket	Day +1 -70.38% 2023-12-05 Day +5 -80.52% 2023-12-11 Best recovery within 5 -70.38% 2023-12-05 Five sessions later the drop was 44.8% bigger, at -80.52%. Month end -88.08% on 2023-12-29
Close before and after $1,540.00 to $683.90 split-adjusted Session open, high, low $999.80, $1,000.00, $630.00 Opening gap -35.08% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 9,795 shares, $6,698,801 Relative volume 130.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
9	COGT	-53.01%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM) 12/09/2023 13:30 ET intraday Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) 12/11/2023	Day +1 -48.50% 2023-12-12 Day +5 -47.80% 2023-12-18 Best recovery within 5 -42.59% 2023-12-14 9.8% of the drop was recovered five sessions later. Month end -31.94% on 2023-12-29
Close before and after $8.64 to $4.06 split-adjusted Session open, high, low $4.29, $4.59, $3.67 Opening gap -50.35% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 20,991,897 shares, $85,227,102 Relative volume 21.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
10	BETS Also on the opposite board this month on both boards	-51.73%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Bit Brother Limited Announces Pricing of $12.0 Million Registered Direct Offering 12/05/2023 14:29 ET intraday	Day +1 -49.57% 2023-12-06 Day +5 -84.29% 2023-12-12 Best recovery within 5 -49.57% 2023-12-06 Five sessions later the drop was 62.9% bigger, at -84.29%. Month end -84.58% on 2023-12-29
Close before and after $69.40 to $33.50 as traded Session open, high, low $60.00, $100.00, $26.20 Opening gap -13.54% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 892,348 shares, $29,893,658 Relative volume 16.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
11	IBIO	-50.00%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	iBio, Inc. Announces Pricing of $4.5 Million Public Offering 12/05/2023 08:00 ET premarket	Day +1 -42.96% 2023-12-06 Day +5 -56.60% 2023-12-12 Best recovery within 5 -42.96% 2023-12-06 Five sessions later the drop was 13.2% bigger, at -56.60%. Month end -49.26% on 2023-12-29
Close before and after $2.70 to $1.35 split-adjusted Session open, high, low $1.57, $1.64, $1.30 Opening gap -41.85% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 3,108,331 shares, $4,196,247 Relative volume 192.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
12	GMM under $25M today	-49.91%	2023-12-29 against the close of 2023-12-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Global Mofy Metaverse Limited Announces $10 Million Follow-on Offering 12/29/2023 09:42 ET intraday	Day +1 -54.49% 2024-01-02 Day +5 -66.52% 2024-01-08 Best recovery within 5 -54.49% 2024-01-02 Five sessions later the drop was 33.3% bigger, at -66.52%. Month end -49.91% on 2023-12-29 same session This month ended before the fifth session after the move.
Close before and after $8,355.00 to $4,185.00 split-adjusted Session open, high, low $6,150.00, $7,687.43, $3,892.50 Opening gap -26.39% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 954 shares, $3,992,490 Relative volume 2.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
13	CARA under $25M today	-48.85%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis 12/18/2023 07:00 ET premarket	Day +1 -49.50% 2023-12-19 Day +5 -43.88% 2023-12-26 Best recovery within 5 -43.88% 2023-12-26 10.2% of the drop was recovered five sessions later. Month end -39.59% on 2023-12-29
Close before and after $44.28 to $22.65 as traded Session open, high, low $42.12, $42.12, $20.46 Opening gap -4.88% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 179,450 shares, $4,064,112 Relative volume 12.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
14	CYN under $25M today Also on the opposite board this month on both boards	-47.00%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Cyngn Announces Pricing of $5.0 Million Public Offering of Common Stock 12/08/2023 09:00 ET premarket	Day +1 -57.47% 2023-12-11 Day +5 -62.25% 2023-12-15 Best recovery within 5 -57.47% 2023-12-11 Five sessions later the drop was 32.4% bigger, at -62.25%. Month end -63.82% on 2023-12-29
Close before and after $6,000.00 to $3,180.00 split-adjusted Session open, high, low $3,222.00, $3,450.00, $2,965.50 Opening gap -46.30% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 2,125 shares, $6,757,500 Relative volume 157.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	POL	-46.91%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Polished.com Acknowledges Recent Trading Activity 12/20/2023 17:00 ET after hours	Day +1 -40.34% 2023-12-22 Day +5 -20.76% 2023-12-29 Best recovery within 5 -20.76% 2023-12-29 55.7% of the drop was recovered five sessions later. Month end -20.76% on 2023-12-29
Close before and after $7.61 to $4.04 as traded Session open, high, low $4.85, $5.19, $3.61 Opening gap -36.27% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 8,113,373 shares, $32,778,027 Relative volume 130.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	BLUE More than one ranked move this month 2+ ranked moves	-45.68%	2023-12-20 against the close of 2023-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock 12/19/2023 21:41 ET after hours	Day +1 -43.62% 2023-12-21 Day +5 -41.98% 2023-12-28 Best recovery within 5 -41.98% 2023-12-28 8.1% of the drop was recovered five sessions later. Month end -43.21% on 2023-12-29
Close before and after $48.60 to $26.40 as traded Session open, high, low $26.10, $28.00, $25.20 Opening gap -46.30% Close inside the session range 0.43 of the range, where 1.00 is the high Session volume 6,268,237 shares, $165,481,457 Relative volume 23.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	REPL	-45.21%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Replimune Shares Initial Primary Analysis Results from CERPASS Clinical Trial in Advanced Cutaneous Squamous Cell Carcinoma and Presents New Data from IGNYTE Clinical Trial of RP1 in Anti-PD1 Failed Melanoma and Non-Melanoma Skin Cancers 12/05/2023 07:00 ET premarket	Day +1 -40.26% 2023-12-06 Day +5 -40.02% 2023-12-12 Best recovery within 5 -38.31% 2023-12-07 11.5% of the drop was recovered five sessions later. Month end -31.57% on 2023-12-29
Close before and after $12.32 to $6.75 split-adjusted Session open, high, low $6.10, $7.23, $5.89 Opening gap -50.49% Close inside the session range 0.64 of the range, where 1.00 is the high Session volume 13,908,703 shares, $93,883,745 Relative volume 16.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	CKPT	-44.88%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer 12/18/2023 07:00 ET premarket	Day +1 -47.29% 2023-12-19 Day +5 -37.35% 2023-12-26 Best recovery within 5 -37.35% 2023-12-26 16.8% of the drop was recovered five sessions later. Month end -31.02% on 2023-12-29
Close before and after $3.32 to $1.83 as traded Session open, high, low $1.54, $1.97, $1.36 Opening gap -53.61% Close inside the session range 0.77 of the range, where 1.00 is the high Session volume 7,885,664 shares, $14,430,765 Relative volume 11.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
19	POLA under $25M today	-44.52%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Polar Power, Inc. Announces Proposed Public Offering of Common Stock 11/30/2023 17:25 ET after hours Polar Power, Inc. Announces Pricing of Public Offering 11/30/2023	Day +1 -36.72% 2023-12-04 Day +5 -46.96% 2023-12-08 Best recovery within 5 -36.72% 2023-12-04 Five sessions later the drop was 5.5% bigger, at -46.96%. Month end -50.34% on 2023-12-29
Close before and after $5.74 to $3.19 split-adjusted Session open, high, low $3.07, $3.29, $2.84 Opening gap -46.53% Close inside the session range 0.77 of the range, where 1.00 is the high Session volume 287,808 shares, $916,668 Relative volume 140.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
20	GGE under $25M today More than one ranked move this month 2+ ranked moves	-44.08%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Green Giant Inc. Announces Pricing of Public Offering 12/12/2023 09:00 ET premarket	Day +1 -51.25% 2023-12-13 Day +5 -66.45% 2023-12-19 Best recovery within 5 -50.72% 2023-12-14 Five sessions later the drop was 50.7% bigger, at -66.45%. Month end -65.66% on 2023-12-29
Close before and after $0.1520 to $0.0850 as traded Session open, high, low $0.1300, $0.1308, $0.0826 Opening gap -14.47% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 32,805,415 shares, $2,788,460 Relative volume 279.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
21	PCT	-43.55%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	PureCycle Provides Ironton Operations Update 12/18/2023 07:45 ET premarket	Day +1 -28.83% 2023-12-19 Day +5 -20.16% 2023-12-26 Best recovery within 5 -20.16% 2023-12-26 53.7% of the drop was recovered five sessions later. Month end -18.35% on 2023-12-29
Close before and after $4.96 to $2.80 split-adjusted Session open, high, low $3.47, $3.54, $2.54 Opening gap -30.04% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 23,917,790 shares, $66,969,812 Relative volume 8.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
22	GPCR	-42.82%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study 12/18/2023 07:30 ET premarket	Day +1 -37.07% 2023-12-19 Day +5 -39.96% 2023-12-26 Best recovery within 5 -37.07% 2023-12-19 6.7% of the drop was recovered five sessions later. Month end -31.10% on 2023-12-29
Close before and after $59.16 to $33.83 split-adjusted Session open, high, low $31.90, $40.30, $26.61 Opening gap -46.08% Close inside the session range 0.53 of the range, where 1.00 is the high Session volume 15,064,117 shares, $509,619,078 Relative volume 30.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
23	ACHV release reads positive	-42.20%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 42.20%	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences 12/11/2023 16:30 ET after hours	Day +1 -39.08% 2023-12-13 Day +5 -36.70% 2023-12-19 Best recovery within 5 -36.70% 2023-12-19 13.0% of the drop was recovered five sessions later. Month end -24.40% on 2023-12-29
Close before and after $5.45 to $3.15 split-adjusted Session open, high, low $3.89, $3.90, $3.03 Opening gap -28.62% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 1,721,099 shares, $5,421,462 Relative volume 45.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
24	PHIO under $25M today	-42.14%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds 12/07/2023 08:00 ET premarket	Day +1 -41.36% 2023-12-08 Day +5 -53.46% 2023-12-14 Best recovery within 5 -41.36% 2023-12-08 Five sessions later the drop was 26.9% bigger, at -53.46%. Month end -52.20% on 2023-12-29
Close before and after $14.31 to $8.28 split-adjusted Session open, high, low $8.71, $9.18, $8.01 Opening gap -39.16% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 305,001 shares, $2,525,408 Relative volume 79.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	MGRX under $25M today	-40.97%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering 12/15/2023 10:39 ET intraday	Day +1 -46.53% 2023-12-18 Day +5 -44.24% 2023-12-22 Best recovery within 5 -44.24% 2023-12-20 Five sessions later the drop was 8.0% bigger, at -44.24%. Month end -46.76% on 2023-12-29
Close before and after $7.80 to $4.61 split-adjusted Session open, high, low $5.22, $6.75, $4.43 Opening gap -33.09% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 252,697 shares, $1,163,670 Relative volume 22.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	BLUE More than one ranked move this month 2+ ranked moves	-40.54%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events 12/08/2023 12:35 ET intraday bluebird bio Details Plans for the Commercial Launch of LYFGENIA™ Gene Therapy for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events 12/08/2023	Day +1 -36.17% 2023-12-11 Day +5 -32.02% 2023-12-15 Best recovery within 5 -31.39% 2023-12-14 21.0% of the drop was recovered five sessions later. Month end -71.31% on 2023-12-29
Close before and after $96.20 to $57.20 as traded Session open, high, low $102.00, $110.60, $53.80 Opening gap +6.03% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 2,706,344 shares, $154,802,877 Relative volume 11.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	GGE under $25M today More than one ranked move this month 2+ ranked moves	-40.13%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Green Giant Inc. Announces Proposed Public Offering 12/08/2023 16:05 ET after hours	Day +1 -66.52% 2023-12-12 Day +5 -76.09% 2023-12-18 Best recovery within 5 -66.52% 2023-12-12 Five sessions later the drop was 89.6% bigger, at -76.09%. Month end -79.44% on 2023-12-29
Close before and after $0.2539 to $0.1520 as traded Session open, high, low $0.1573, $0.1690, $0.1472 Opening gap -38.05% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 10,638,360 shares, $1,617,031 Relative volume 133.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
28	CLNN	-38.83%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory catalyst from a later release the same session	Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension 12/21/2023 07:00 ET premarket Clene Provides Update on ALS Clinical Development Meeting With FDA 12/21/2023	Day +1 -43.69% 2023-12-22 Day +5 -42.41% 2023-12-29 Best recovery within 5 -42.41% 2023-12-29 Five sessions later the drop was 9.2% bigger, at -42.41%. Month end -42.41% on 2023-12-29
Close before and after $10.30 to $6.30 split-adjusted Session open, high, low $6.76, $7.00, $5.52 Opening gap -34.37% Close inside the session range 0.53 of the range, where 1.00 is the high Session volume 444,792 shares, $2,802,190 Relative volume 27.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
29	BYTS release reads positive	-38.19%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell Release reads positive, stock fell 38.19%	Airship AI Holdings Completes Business Combination with BYTE Acquisition Corp. 12/21/2023 11:55 ET intraday	Day +1 no data Day +5 no data Best recovery within 5 no data Month-end is not shown: no closing price is available for 2023-12-29.
Close before and after $10.50 to $6.49 as traded Session open, high, low $9.42, $9.42, $5.28 Opening gap -10.28% Close inside the session range 0.29 of the range, where 1.00 is the high Session volume 334,431 shares, $2,170,457 Relative volume 189.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	TRKA More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-37.50%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Troika Media Group Inc. Receives Notice from Nasdaq Regarding Delisting 12/07/2023 17:21 ET after hours	Day +1 -55.36% 2023-12-11 Day +5 -75.26% 2023-12-15 Best recovery within 5 -55.36% 2023-12-11 Five sessions later the drop was 100.7% bigger, at -75.26%. Month end -80.93% on 2023-12-29
Close before and after $0.5376 to $0.3360 as traded Session open, high, low $0.4000, $0.5056, $0.3079 Opening gap -25.60% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 7,034,713 shares, $2,363,664 Relative volume 23.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	JOAN	-37.03%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	JOANN Announces Third Quarter Fiscal 2024 Results And Increases Top-Line Full Year Outlook 12/04/2023 16:05 ET after hours	Day +1 -37.35% 2023-12-06 Day +5 -36.57% 2023-12-12 Best recovery within 5 -33.82% 2023-12-07 1.2% of the drop was recovered five sessions later. Month end -49.89% on 2023-12-29
Close before and after $0.8900 to $0.5604 as traded Session open, high, low $0.8271, $0.8500, $0.5555 Opening gap -7.07% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 1,101,262 shares, $617,147 Relative volume 7.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	TNXP	-36.78%	2023-12-20 against the close of 2023-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline Results in Second Positive Phase 3 Clinical Trial of TNX-102 SL for the Management of Fibromyalgia 12/20/2023 10:30 ET intraday Tonix Pharmaceuticals Announces Registered Direct Offering of up to $144 Million 12/20/2023	Day +1 -36.71% 2023-12-21 Day +5 -31.51% 2023-12-28 Best recovery within 5 -30.84% 2023-12-27 14.3% of the drop was recovered five sessions later. Month end -32.84% on 2023-12-29
Close before and after $1,920.32 to $1,214.08 split-adjusted Session open, high, low $2,016.00, $2,176.00, $1,200.00 Opening gap +4.98% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 4,257 shares, $5,168,339 Relative volume 20.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	AISP	-34.51%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Airship AI Starts Delivery of $10.9 Million US Government Contracts for Advanced Video and Sensor Management 12/22/2023 08:31 ET premarket	Day +1 -46.38% 2023-12-26 Day +5 -75.35% 2024-01-02 Best recovery within 5 -46.38% 2023-12-26 Five sessions later the drop was 118.3% bigger, at -75.35%. Month end -73.81% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $6.49 to $4.25 split-adjusted Session open, high, low $7.50, $7.71, $3.89 Opening gap +15.56% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 1,372,062 shares, $5,831,264 Relative volume 465.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	MHUA	-33.95%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering 12/28/2023 09:00 ET premarket	Day +1 -45.39% 2023-12-29 Day +5 -56.83% 2024-01-05 Best recovery within 5 -45.39% 2023-12-29 Five sessions later the drop was 67.4% bigger, at -56.83%. Month end -45.39% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $271.00 to $179.00 as traded Session open, high, low $258.00, $260.38, $173.00 Opening gap -4.80% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 5,495 shares, $983,605 Relative volume 1.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	ROI Also on the opposite board this month release reads positive on both boards	-33.72%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 33.72%	Ault Alliance Subsidiary, RiskOn International, to Announce Its New Generative AI Platform and Technology Partner on January 3, 2024 12/28/2023 06:30 ET premarket	Day +1 -22.63% 2023-12-29 Day +5 -55.72% 2024-01-05 Best recovery within 5 +6.74% 2024-01-02 Five sessions later the drop was 65.2% bigger, at -55.72%. Month end -22.63% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $0.4300 to $0.2850 as traded Session open, high, low $0.3654, $0.3848, $0.2850 Opening gap -15.02% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 14,946,090 shares, $4,259,636 Relative volume 5.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
36	VLD under $25M today More than one ranked move this month 2+ ranked moves	-33.67%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Velo3D, Inc. Announces $18 Million Registered Direct Offering 12/28/2023 07:50 ET premarket Velo3D, Inc. Enters Debt Amendment Agreement with Existing Note Holder 12/28/2023	Day +1 -36.98% 2023-12-29 Day +5 -45.38% 2024-01-05 Best recovery within 5 -36.98% 2023-12-29 Five sessions later the drop was 34.8% bigger, at -45.38%. Month end -36.98% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $22.08 to $14.65 as traded Session open, high, low $16.99, $16.99, $14.46 Opening gap -23.05% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 644,564 shares, $9,441,251 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	CXM	-33.47%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sprinklr Announces Third Quarter Fiscal 2024 Results 12/06/2023 16:05 ET after hours Sprinklr Empowers Businesses to Deploy and Scale Generative AI-powered Conversational Bots 12/07/2023	Day +1 -32.57% 2023-12-08 Day +5 -31.86% 2023-12-14 Best recovery within 5 -31.32% 2023-12-13 4.8% of the drop was recovered five sessions later. Month end -27.90% on 2023-12-29
Close before and after $16.70 to $11.11 split-adjusted Session open, high, low $11.99, $12.11, $10.96 Opening gap -28.20% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 24,758,965 shares, $275,072,101 Relative volume 22.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	CTSO under $25M today	-33.44%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation 12/28/2023 07:00 ET premarket	Day +1 -31.90% 2023-12-29 Day +5 -43.56% 2024-01-05 Best recovery within 5 -31.90% 2023-12-29 Five sessions later the drop was 30.3% bigger, at -43.56%. Month end -31.90% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $1.63 to $1.09 split-adjusted Session open, high, low $1.08, $1.10, $0.9109 Opening gap -33.74% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 6,219,508 shares, $6,748,166 Relative volume 36.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	DBI	-33.33%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Designer Brands Inc. Reports Third Quarter 2023 Financial Results 12/05/2023 06:45 ET premarket	Day +1 -33.96% 2023-12-06 Day +5 -34.27% 2023-12-12 Best recovery within 5 -31.62% 2023-12-07 Five sessions later the drop was 2.8% bigger, at -34.27%. Month end -30.91% on 2023-12-29
Close before and after $12.81 to $8.54 split-adjusted Session open, high, low $8.66, $8.97, $8.38 Opening gap -32.40% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 10,450,289 shares, $89,245,468 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	EOSE Also on the opposite board this month on both boards	-32.74%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Eos Energy Announces Launch of Proposed $40M Public Offering 12/14/2023 16:26 ET after hours Eos Energy Announces Pricing of $50 Million Public Offering 12/14/2023	Day +1 -33.33% 2023-12-18 Day +5 -30.36% 2023-12-22 Best recovery within 5 -30.36% 2023-12-22 7.3% of the drop was recovered five sessions later. Month end -35.12% on 2023-12-29
Close before and after $1.68 to $1.13 split-adjusted Session open, high, low $1.13, $1.14, $1.01 Opening gap -32.74% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 43,376,509 shares, $49,015,455 Relative volume 9.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
41	ASYS	-31.55%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Amtech Fourth Quarter Fiscal 2023 Business Update 12/13/2023 16:05 ET after hours	Day +1 -34.39% 2023-12-15 Day +5 -29.38% 2023-12-21 Best recovery within 5 -29.38% 2023-12-21 6.9% of the drop was recovered five sessions later. Month end -29.88% on 2023-12-29
Close before and after $5.99 to $4.10 split-adjusted Session open, high, low $4.14, $4.40, $4.05 Opening gap -30.88% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 2,020,837 shares, $8,285,432 Relative volume 99.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	XFOR	-31.15%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023 12/09/2023 12:00 ET intraday	Day +1 -29.39% 2023-12-12 Day +5 -20.83% 2023-12-18 Best recovery within 5 -18.90% 2023-12-15 33.1% of the drop was recovered five sessions later. Month end -4.75% on 2023-12-29
Close before and after $26.41 to $18.18 split-adjusted Session open, high, low $20.70, $21.00, $17.70 Opening gap -21.62% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 551,025 shares, $10,019,288 Relative volume 10.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
43	MIST	-30.90%	2023-12-26 against the close of 2023-12-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT 12/26/2023 07:00 ET premarket	Day +1 -34.72% 2023-12-27 Day +5 -38.89% 2024-01-03 Best recovery within 5 -34.72% 2023-12-27 Five sessions later the drop was 25.9% bigger, at -38.89%. Month end -42.01% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $2.88 to $1.99 split-adjusted Session open, high, low $2.00, $2.06, $1.86 Opening gap -30.56% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 3,026,529 shares, $6,022,793 Relative volume 16.4x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
44	MLGO More than one ranked move this month Also on the opposite board this month release reads positive 2+ ranked moves on both boards	-30.67%	2023-12-26 against the close of 2023-12-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury Release reads positive, stock fell 30.67%	MicroAlgo Inc. Announced Bitcoin Trading Prediction Algorithm Based on Machine Learning and Technical Indicators 12/26/2023 10:59 ET intraday	Day +1 -47.85% 2023-12-27 Day +5 -54.84% 2024-01-03 Best recovery within 5 -44.05% 2023-12-29 Five sessions later the drop was 78.8% bigger, at -54.84%. Month end -44.05% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $9,780.00 to $6,780.00 split-adjusted Session open, high, low $9,900.00, $11,880.00, $5,522.40 Opening gap +1.23% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 2,611 shares, $17,702,580 Relative volume 14.1x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
45	WVE	-30.42%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency 12/06/2023 16:08 ET after hours Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants 12/06/2023 Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares 12/07/2023	Day +1 -34.43% 2023-12-08 Day +5 -33.62% 2023-12-14 Best recovery within 5 -32.61% 2023-12-13 Five sessions later the drop was 10.5% bigger, at -33.62%. Month end -26.49% on 2023-12-29
Close before and after $6.87 to $4.78 split-adjusted Session open, high, low $4.63, $4.95, $4.60 Opening gap -32.61% Close inside the session range 0.51 of the range, where 1.00 is the high Session volume 5,187,882 shares, $24,798,076 Relative volume 19.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	BMEA More than one ranked move this month 2+ ranked moves	-30.31%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results catalyst from a later release the same session	Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts 12/09/2023 17:30 ET after hours Biomea Fusion Presents Achievement of Minimal Residual Disease Negativity (MRD-neg) in First Complete Responder from Ongoing Phase I Study (COVALENT-101) of BMF-219 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) at the 2023 ASH Annual Meeting 12/11/2023	Day +1 -19.66% 2023-12-12 Day +5 -17.17% 2023-12-18 Best recovery within 5 -13.38% 2023-12-13 43.4% of the drop was recovered five sessions later. Month end -14.03% on 2023-12-29
Close before and after $16.89 to $11.77 split-adjusted Session open, high, low $12.75, $12.94, $10.37 Opening gap -24.51% Close inside the session range 0.55 of the range, where 1.00 is the high Session volume 7,550,846 shares, $88,873,457 Relative volume 14.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
47	CMTL	-29.68%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Comtech Announces Results for its First Quarter of Fiscal 2024 and Provides Second Quarter Fiscal 2024 Financial Targets 12/07/2023 16:04 ET after hours	Day +1 -37.04% 2023-12-11 Day +5 -36.64% 2023-12-15 Best recovery within 5 -36.64% 2023-12-15 Five sessions later the drop was 23.5% bigger, at -36.64%. Month end -32.56% on 2023-12-29
Close before and after $12.50 to $8.79 split-adjusted Session open, high, low $11.60, $11.60, $8.74 Opening gap -7.20% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 2,409,894 shares, $21,182,968 Relative volume 17.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	CVAC	-29.55%	2023-12-19 against the close of 2023-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE 12/19/2023 09:35 ET intraday	Day +1 -31.96% 2023-12-20 Day +5 -27.15% 2023-12-27 Best recovery within 5 -27.15% 2023-12-27 8.1% of the drop was recovered five sessions later. Month end -27.66% on 2023-12-29
Close before and after $5.82 to $4.10 as traded Session open, high, low $3.61, $4.68, $3.41 Opening gap -37.97% Close inside the session range 0.54 of the range, where 1.00 is the high Session volume 16,572,804 shares, $67,948,496 Relative volume 35.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	PHUN	-29.14%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Phunware Announces Pricing of $2.8 Million Public Offering 12/07/2023 09:51 ET intraday	Day +1 -28.59% 2023-12-08 Day +5 -39.06% 2023-12-14 Best recovery within 5 -28.59% 2023-12-08 Five sessions later the drop was 34.0% bigger, at -39.06%. Month end -35.94% on 2023-12-29
Close before and after $6.40 to $4.54 split-adjusted Session open, high, low $5.71, $5.97, $4.51 Opening gap -10.86% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 407,698 shares, $1,848,910 Relative volume 6.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	KULR	-29.10%	2023-12-20 against the close of 2023-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	KULR Announces Proposed Public Offering of Common Stock 12/19/2023 16:30 ET after hours KULR Announces Pricing of $900,000 Public Offering of Common Stock 12/20/2023	Day +1 -29.37% 2023-12-21 Day +5 -32.44% 2023-12-28 Best recovery within 5 -29.37% 2023-12-21 Five sessions later the drop was 11.5% bigger, at -32.44%. Month end -37.48% on 2023-12-29
Close before and after $2.37 to $1.68 split-adjusted Session open, high, low $1.66, $1.87, $1.64 Opening gap -30.08% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 679,287 shares, $1,140,115 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	SALM	-28.51%	2023-12-29 against the close of 2023-12-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Salem Media Group Announces Voluntary Delisting from the Nasdaq Global Market 12/29/2023 12:11 ET intraday INSERTING and REPLACING Salem Media Group Announces Voluntary Delisting from the Nasdaq Global Market 12/29/2023	Day +1 -34.02% 2024-01-02 Day +5 -40.24% 2024-01-08 Best recovery within 5 -34.02% 2024-01-02 Five sessions later the drop was 41.1% bigger, at -40.24%. Month end -28.51% on 2023-12-29 same session This month ended before the fifth session after the move.
Close before and after $0.5455 to $0.3900 split-adjusted Session open, high, low $0.5411, $0.5451, $0.3701 Opening gap -0.81% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 1,043,764 shares, $407,068 Relative volume 33.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	RCAT	-27.63%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Red Cat Holdings, Inc. Announces Proposed Public Offering of Common Stock 12/06/2023 17:15 ET after hours Red Cat Holdings, Inc. Announces Pricing of Public Offering 12/06/2023	Day +1 -22.38% 2023-12-08 Day +5 -23.04% 2023-12-14 Best recovery within 5 -21.06% 2023-12-11 16.6% of the drop was recovered five sessions later. Month end +15.77% on 2023-12-29
Close before and after $0.7601 to $0.5501 split-adjusted Session open, high, low $0.5473, $0.5995, $0.5250 Opening gap -28.00% Close inside the session range 0.34 of the range, where 1.00 is the high Session volume 2,978,374 shares, $1,638,404 Relative volume 42.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	PACI	-27.50%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	PROOF Acquisition Corp I Announces Intention to Transfer to NYSE American LLC Upon Completion of Business Combination with Volato 11/30/2023 16:58 ET after hours	Day +1 no data Day +5 no data Best recovery within 5 no data Month-end is not shown: no closing price is available for 2023-12-29.
Close before and after $20.00 to $14.50 as traded Session open, high, low $18.02, $18.02, $13.11 Opening gap -9.90% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 35,965 shares, $521,493 Relative volume 5.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	LNTH	-26.88%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer 12/18/2023 07:30 ET premarket	Day +1 -21.23% 2023-12-19 Day +5 -19.57% 2023-12-26 Best recovery within 5 -19.57% 2023-12-26 27.2% of the drop was recovered five sessions later. Month end -18.46% on 2023-12-29
Close before and after $76.04 to $55.60 split-adjusted Session open, high, low $60.93, $64.00, $54.85 Opening gap -19.87% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 9,242,311 shares, $513,872,492 Relative volume 11.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
55	NOGN	-26.49%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Nogin Initiates Strategic Financial Restructuring; Operations to Continue Uninterrupted 12/06/2023 17:00 ET after hours	Day +1 -14.46% 2023-12-08 Day +5 -25.11% 2023-12-14 Best recovery within 5 -6.18% 2023-12-11 5.2% of the drop was recovered five sessions later. Month end -92.60% on 2023-12-29
Close before and after $0.1812 to $0.1332 as traded Session open, high, low $0.1272, $0.1721, $0.1200 Opening gap -29.80% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 3,378,705 shares, $450,044 Relative volume 6.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	SNGX under $25M today	-25.53%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery 12/01/2023 07:30 ET premarket	Day +1 -25.54% 2023-12-04 Day +5 -29.82% 2023-12-08 Best recovery within 5 -16.34% 2023-12-06 Five sessions later the drop was 16.8% bigger, at -29.82%. Month end -22.75% on 2023-12-29
Close before and after $15.68 to $11.68 split-adjusted Session open, high, low $12.16, $14.24, $11.38 Opening gap -22.43% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 439,318 shares, $5,131,234 Relative volume 163.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	BTDR release reads positive	-25.42%	2023-12-29 against the close of 2023-12-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings Release reads positive, stock fell 25.42%	Bitdeer Technologies Group (NASDAQ: BTDR) Q3 Earnings Highlights: Net Loss Slashed, Gross Profit And Gross Margin Up 12/29/2023 09:00 ET premarket	Day +1 -32.83% 2024-01-02 Day +5 -31.32% 2024-01-08 Best recovery within 5 -31.32% 2024-01-08 Five sessions later the drop was 23.2% bigger, at -31.32%. Month end -25.42% on 2023-12-29 same session This month ended before the fifth session after the move.
Close before and after $13.22 to $9.86 split-adjusted Session open, high, low $13.02, $13.02, $9.11 Opening gap -1.51% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 6,553,966 shares, $64,622,105 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
58	PCSA under $25M today More than one ranked move this month release reads positive 2+ ranked moves	-25.40%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory Release reads positive, stock fell 25.40%	Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine 12/13/2023 09:00 ET premarket	Day +1 -19.11% 2023-12-14 Day +5 -48.21% 2023-12-20 Best recovery within 5 -11.84% 2023-12-15 Five sessions later the drop was 89.8% bigger, at -48.21%. Month end -58.74% on 2023-12-29
Close before and after $405.50 to $302.50 split-adjusted Session open, high, low $400.00, $400.00, $226.25 Opening gap -1.36% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 6,895 shares, $2,085,738 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	BCLI under $25M today release reads positive	-25.33%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory Release reads positive, stock fell 25.33%	BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS 12/07/2023 08:40 ET premarket	Day +1 -32.63% 2023-12-08 Day +5 -26.00% 2023-12-14 Best recovery within 5 -26.00% 2023-12-14 Five sessions later the drop was 2.6% bigger, at -26.00%. Month end -8.17% on 2023-12-29
Close before and after $4.46 to $3.33 split-adjusted Session open, high, low $3.90, $4.07, $3.30 Opening gap -12.55% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 408,964 shares, $1,361,850 Relative volume 2.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
60	ARGX	-25.12%	2023-12-20 against the close of 2023-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus 12/20/2023 01:00 ET premarket	Day +1 -21.75% 2023-12-21 Day +5 -15.98% 2023-12-28 Best recovery within 5 -14.60% 2023-12-27 36.4% of the drop was recovered five sessions later. Month end -15.94% on 2023-12-29
Close before and after $452.58 to $338.91 split-adjusted Session open, high, low $345.61, $346.79, $331.52 Opening gap -23.64% Close inside the session range 0.48 of the range, where 1.00 is the high Session volume 5,438,654 shares, $1,843,214,227 Relative volume 19.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
61	MLGO More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-24.78%	2023-12-27 against the close of 2023-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury	MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems 12/27/2023 10:00 ET intraday	Day +1 -26.55% 2023-12-28 Day +5 -32.64% 2024-01-04 Best recovery within 5 -19.29% 2023-12-29 Five sessions later the drop was 31.7% bigger, at -32.64%. Month end -19.29% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $6,780.00 to $5,100.00 split-adjusted Session open, high, low $6,900.00, $6,900.00, $4,410.60 Opening gap +1.77% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 2,196 shares, $11,199,600 Relative volume 11.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	IPA	-24.68%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	IPA Announces Proposed Public Offering of Common Shares 12/05/2023 16:35 ET after hours IPA Announces Pricing of $1.1 Million Public Offering of Common Shares 12/06/2023	Day +1 -26.62% 2023-12-07 Day +5 -22.08% 2023-12-13 Best recovery within 5 -22.08% 2023-12-13 10.5% of the drop was recovered five sessions later. Month end +11.04% on 2023-12-29
Close before and after $1.54 to $1.16 as traded Session open, high, low $0.9659, $1.27, $0.9400 Opening gap -37.28% Close inside the session range 0.67 of the range, where 1.00 is the high Session volume 1,720,691 shares, $1,996,002 Relative volume 36.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	MYNZ under $25M today	-24.53%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers 12/05/2023 09:01 ET premarket	Day +1 -30.82% 2023-12-06 Day +5 -31.45% 2023-12-12 Best recovery within 5 -28.93% 2023-12-07 Five sessions later the drop was 28.2% bigger, at -31.45%. Month end -27.04% on 2023-12-29
Close before and after $63.60 to $48.00 as traded Session open, high, low $52.00, $54.80, $43.20 Opening gap -18.24% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 62,956 shares, $3,021,888 Relative volume 20.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
64	CAMP	-24.22%	2023-12-19 against the close of 2023-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CalAmp Announces Completion of Strategic Financing with Lynrock Lake 12/18/2023 16:31 ET after hours	Day +1 -21.99% 2023-12-20 Day +5 -10.10% 2023-12-27 Best recovery within 5 -10.10% 2023-12-27 58.3% of the drop was recovered five sessions later. Month end -6.76% on 2023-12-29
Close before and after $6.19 to $4.69 split-adjusted Session open, high, low $6.56, $6.67, $4.49 Opening gap +5.87% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 146,966 shares, $689,564 Relative volume 13.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	NRSN under $25M today Also on the opposite board this month on both boards	-24.16%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	NeuroSense's Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints 12/05/2023 08:00 ET premarket NeuroSense to Report Phase 2b ALS Topline Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints on December 5, 2023 12/04/2023	Day +1 -51.34% 2023-12-06 Day +5 -56.57% 2023-12-12 Best recovery within 5 -46.58% 2023-12-07 Five sessions later the drop was 134.1% bigger, at -56.57%. Month end -47.32% on 2023-12-29
Close before and after $1.49 to $1.13 split-adjusted Session open, high, low $1.04, $1.25, $1.04 Opening gap -30.20% Close inside the session range 0.43 of the range, where 1.00 is the high Session volume 22,010,303 shares, $24,871,642 Relative volume 55.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	CYCC under $25M today	-23.89%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules 12/22/2023 09:15 ET premarket	Day +1 -21.94% 2023-12-26 Day +5 -26.39% 2024-01-02 Best recovery within 5 -19.44% 2023-12-27 Five sessions later the drop was 10.5% bigger, at -26.39%. Month end -25.83% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $3.60 to $2.74 as traded Session open, high, low $2.30, $3.00, $2.20 Opening gap -36.11% Close inside the session range 0.68 of the range, where 1.00 is the high Session volume 220,058 shares, $602,959 Relative volume 16.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	VAPO More than one ranked move this month 2+ ranked moves	-23.86%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX 12/11/2023 06:45 ET premarket	Day +1 -40.61% 2023-12-12 Day +5 -54.31% 2023-12-18 Best recovery within 5 -35.53% 2023-12-14 Five sessions later the drop was 127.6% bigger, at -54.31%. Month end -49.24% on 2023-12-29
Close before and after $1.97 to $1.50 as traded Session open, high, low $1.59, $1.67, $1.47 Opening gap -19.29% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 252,498 shares, $378,747 Relative volume 10.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
68	BLBX	-23.64%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Blackboxstocks, Inc. Signs Definitive Agreement to Acquire Evtec Aluminium, Supplier of Proprietary Parts for the EV, Hybrid, and Performance Automotive Market, with Projected Revenue of US$52 Million for Fiscal Year Ending June 30, 2024 12/13/2023 08:30 ET premarket	Day +1 -24.68% 2023-12-14 Day +5 -29.87% 2023-12-20 Best recovery within 5 -24.68% 2023-12-14 Five sessions later the drop was 26.4% bigger, at -29.87%. Month end -26.75% on 2023-12-29
Close before and after $3.85 to $2.94 as traded Session open, high, low $2.35, $3.60, $2.35 Opening gap -38.96% Close inside the session range 0.47 of the range, where 1.00 is the high Session volume 175,106 shares, $514,812 Relative volume 13.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	NKLA	-23.39%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	NIKOLA CORPORATION ANNOUNCES PROPOSED OFFERINGS OF COMMON STOCK AND CONVERTIBLE SENIOR NOTES 12/06/2023 16:35 ET after hours	Day +1 -27.26% 2023-12-08 Day +5 -7.27% 2023-12-14 Best recovery within 5 -7.27% 2023-12-14 68.9% of the drop was recovered five sessions later. Month end -10.95% on 2023-12-29
Close before and after $29.47 to $22.58 as traded Session open, high, low $23.57, $25.33, $22.50 Opening gap -20.03% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 8,831,456 shares, $199,396,614 Relative volume 5.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	CNSP under $25M today	-23.12%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	CNS Pharmaceuticals Announces Successful Interim Analysis of Efficacy and Safety Data in Potentially Pivotal Study of Berubicin 12/18/2023 08:35 ET premarket	Day +1 -25.43% 2023-12-19 Day +5 -26.01% 2023-12-26 Best recovery within 5 -25.43% 2023-12-19 Five sessions later the drop was 12.5% bigger, at -26.01%. Month end -26.59% on 2023-12-29
Close before and after $51,900.00 to $39,900.00 split-adjusted Session open, high, low $52,800.00, $53,763.00, $34,500.00 Opening gap +1.73% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 19 shares, $758,100 Relative volume 9.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
71	ATHE Also on the opposite board this month on both boards	-22.86%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress 12/04/2023 16:35 ET after hours	Day +1 -29.76% 2023-12-06 Day +5 -42.62% 2023-12-12 Best recovery within 5 -29.76% 2023-12-06 Five sessions later the drop was 86.4% bigger, at -42.62%. Month end -40.71% on 2023-12-29
Close before and after $4.20 to $3.24 split-adjusted Session open, high, low $3.40, $3.81, $3.20 Opening gap -19.05% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 1,182,881 shares, $3,832,534 Relative volume 437.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
72	LGVN under $25M today	-22.84%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 12/21/2023 08:00 ET premarket	Day +1 -17.28% 2023-12-22 Day +5 -16.05% 2023-12-29 Best recovery within 5 -9.88% 2023-12-26 29.7% of the drop was recovered five sessions later. Month end -16.05% on 2023-12-29
Close before and after $16.20 to $12.50 split-adjusted Session open, high, low $12.90, $13.90, $11.50 Opening gap -20.37% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 120,252 shares, $1,503,150 Relative volume 20.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	BCEL	-22.72%	2023-12-26 against the close of 2023-12-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome 12/26/2023 08:30 ET premarket Immunome to Acquire Antibody-Related Assets and Materials from Atreca 12/26/2023	Day +1 -39.98% 2023-12-27 Day +5 -43.84% 2024-01-03 Best recovery within 5 -39.98% 2023-12-27 Five sessions later the drop was 93.0% bigger, at -43.84%. Month end -40.03% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $0.2201 to $0.1701 as traded Session open, high, low $0.2350, $0.2499, $0.1635 Opening gap +6.77% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 10,009,106 shares, $1,702,549 Relative volume 21.7x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
74	FBIO	-22.62%	2023-12-29 against the close of 2023-12-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 12/29/2023 08:20 ET premarket	Day +1 -30.85% 2024-01-02 Day +5 -41.90% 2024-01-08 Best recovery within 5 -30.85% 2024-01-02 Five sessions later the drop was 85.2% bigger, at -41.90%. Month end -22.62% on 2023-12-29 same session This month ended before the fifth session after the move.
Close before and after $3.89 to $3.01 split-adjusted Session open, high, low $3.24, $3.34, $2.94 Opening gap -16.71% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 2,184,451 shares, $6,575,198 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	CCLD Also on the opposite board this month on both boards	-22.56%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	CareCloud Announces Suspension of its Dividends on Non-Convertible Series A and Series B Cumulative Redeemable Perpetual Preferred Stock 12/11/2023 17:17 ET after hours	Day +1 -26.47% 2023-12-13 Day +5 -19.61% 2023-12-19 Best recovery within 5 -19.61% 2023-12-19 13.1% of the drop was recovered five sessions later. Month end +49.02% on 2023-12-29
Close before and after $1.02 to $0.7899 split-adjusted Session open, high, low $1.00, $1.01, $0.7500 Opening gap -1.96% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 280,143 shares, $221,285 Relative volume 9.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	YQ under $25M today	-22.22%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results 12/06/2023 17:00 ET after hours	Day +1 -37.57% 2023-12-08 Day +5 -34.26% 2023-12-14 Best recovery within 5 -25.93% 2023-12-12 Five sessions later the drop was 54.2% bigger, at -34.26%. Month end -23.33% on 2023-12-29
Close before and after $2.70 to $2.10 split-adjusted Session open, high, low $2.60, $2.65, $1.75 Opening gap -3.70% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 32,218 shares, $67,658 Relative volume 4.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
77	FWBI under $25M today Also on the opposite board this month on both boards	-22.14%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company 12/18/2023 06:00 ET premarket	Day +1 -19.65% 2023-12-19 Day +5 -16.48% 2023-12-26 Best recovery within 5 -11.16% 2023-12-22 25.6% of the drop was recovered five sessions later. Month end -4.93% on 2023-12-29
Close before and after $4.42 to $3.44 as traded Session open, high, low $4.50, $4.65, $3.42 Opening gap +1.86% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 185,751 shares, $638,983 Relative volume 13.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
78	VAPO More than one ranked move this month 2+ ranked moves	-22.05%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX 12/14/2023 18:27 ET after hours	Day +1 -29.13% 2023-12-18 Day +5 -31.50% 2023-12-22 Best recovery within 5 -28.74% 2023-12-20 Five sessions later the drop was 42.9% bigger, at -31.50%. Month end -21.26% on 2023-12-29
Close before and after $1.27 to $0.9900 as traded Session open, high, low $1.05, $1.20, $0.8200 Opening gap -17.32% Close inside the session range 0.45 of the range, where 1.00 is the high Session volume 345,889 shares, $342,430 Relative volume 9.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
79	SPWH	-21.62%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sportsman's Warehouse Holdings, Inc. Announces Third Quarter 2023 Financial Results 12/06/2023 16:05 ET after hours	Day +1 -21.80% 2023-12-08 Day +5 -17.67% 2023-12-14 Best recovery within 5 -17.67% 2023-12-14 18.3% of the drop was recovered five sessions later. Month end -19.92% on 2023-12-29
Close before and after $5.32 to $4.17 split-adjusted Session open, high, low $4.80, $4.80, $4.05 Opening gap -9.77% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 3,414,132 shares, $14,236,930 Relative volume 7.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	PCSA under $25M today More than one ranked move this month 2+ ranked moves	-21.36%	2023-12-19 against the close of 2023-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine 12/19/2023 09:00 ET premarket	Day +1 -36.36% 2023-12-20 Day +5 -37.80% 2023-12-27 Best recovery within 5 -31.91% 2023-12-22 Five sessions later the drop was 77.0% bigger, at -37.80%. Month end -49.30% on 2023-12-29
Close before and after $330.00 to $259.50 split-adjusted Session open, high, low $325.00, $325.00, $235.10 Opening gap -1.52% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 4,024 shares, $1,044,228 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	YEXT	-21.11%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Yext Announces Third Quarter Fiscal 2024 Results 12/05/2023 16:04 ET after hours	Day +1 -23.40% 2023-12-07 Day +5 -19.12% 2023-12-13 Best recovery within 5 -18.97% 2023-12-08 9.4% of the drop was recovered five sessions later. Month end -15.98% on 2023-12-29
Close before and after $7.01 to $5.53 split-adjusted Session open, high, low $5.74, $6.00, $5.37 Opening gap -18.19% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 6,545,849 shares, $36,198,545 Relative volume 10.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	RGS	-21.05%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	NYSE Announces Intent to Commence Delisting Proceedings for Regis Corporation Common Stock; Opportunity to Appeal 12/14/2023 06:30 ET premarket	Day +1 -23.74% 2023-12-15 Day +5 -35.66% 2023-12-21 Best recovery within 5 -23.74% 2023-12-15 Five sessions later the drop was 69.4% bigger, at -35.66%. Month end +1.50% on 2023-12-29
Close before and after $9.31 to $7.35 split-adjusted Session open, high, low $7.96, $8.69, $7.32 Opening gap -14.50% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 90,840 shares, $667,674 Relative volume 2.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	CSPI	-20.90%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CSP Inc. Reports 19% Year-over-Year Revenue Growth for Fiscal 2023; Net Income per Common Share - Diluted Increases 161% to $1.09 12/12/2023 08:30 ET premarket	Day +1 -14.10% 2023-12-13 Day +5 -14.23% 2023-12-19 Best recovery within 5 -14.10% 2023-12-13 31.9% of the drop was recovered five sessions later. Month end -13.88% on 2023-12-29
Close before and after $11.32 to $8.95 split-adjusted Session open, high, low $10.48, $10.48, $8.22 Opening gap -7.38% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 359,576 shares, $3,218,205 Relative volume 11.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	KROS	-20.53%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition 12/11/2023 06:00 ET premarket	Day +1 -16.80% 2023-12-12 Day +5 -7.85% 2023-12-18 Best recovery within 5 -5.33% 2023-12-14 61.8% of the drop was recovered five sessions later. Month end +11.53% on 2023-12-29
Close before and after $35.65 to $28.33 split-adjusted Session open, high, low $34.15, $34.15, $27.91 Opening gap -4.21% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 1,559,856 shares, $44,190,720 Relative volume 5.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
85	CGC	-20.45%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Canopy Growth Announces Effective Date of Share Consolidation 12/13/2023 07:00 ET premarket	Day +1 -20.43% 2023-12-14 Day +5 -29.94% 2023-12-20 Best recovery within 5 -20.43% 2023-12-14 Five sessions later the drop was 46.4% bigger, at -29.94%. Month end -25.41% on 2023-12-29
Close before and after $6.85 to $5.45 split-adjusted Session open, high, low $5.80, $5.99, $5.00 Opening gap -15.34% Close inside the session range 0.45 of the range, where 1.00 is the high Session volume 9,099,849 shares, $49,594,177 Relative volume 4.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	BLUE More than one ranked move this month 2+ ranked moves	-20.33%	2023-12-19 against the close of 2023-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	bluebird bio, Inc. Announces Proposed Public Offering of Common Stock 12/18/2023 16:01 ET after hours	Day +1 -56.72% 2023-12-20 Day +5 -54.10% 2023-12-27 Best recovery within 5 -54.10% 2023-12-22 Five sessions later the drop was 166.1% bigger, at -54.10%. Month end -54.75% on 2023-12-29
Close before and after $61.00 to $48.60 as traded Session open, high, low $53.00, $55.58, $45.20 Opening gap -13.11% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 1,902,864 shares, $92,479,190 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	COCH	-20.26%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Envoy Medical to Host Fireside Chat Event December 7 12/04/2023 08:15 ET premarket	Day +1 -18.97% 2023-12-05 Day +5 -5.60% 2023-12-11 Best recovery within 5 -5.60% 2023-12-11 72.4% of the drop was recovered five sessions later. Month end -21.96% on 2023-12-29
Close before and after $2.32 to $1.85 split-adjusted Session open, high, low $2.25, $2.40, $1.61 Opening gap -3.02% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 77,558 shares, $143,482 Relative volume 4.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
88	TELL	-20.24%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change catalyst from a later release the same session	Martin Houston Becomes Chairman of Tellurian Inc. 12/08/2023 16:54 ET after hours Tellurian Board of Directors names Daniel Belhumeur as President, Meredith Mouer as General Counsel and Chief Compliance Officer 12/11/2023	Day +1 -19.35% 2023-12-12 Day +5 -1.41% 2023-12-18 Best recovery within 5 -1.41% 2023-12-18 93.0% of the drop was recovered five sessions later. Month end +1.27% on 2023-12-29
Close before and after $0.7461 to $0.5951 as traded Session open, high, low $0.7895, $0.8295, $0.5700 Opening gap +5.82% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 83,630,631 shares, $49,768,589 Relative volume 2.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
89	EMKR	-20.17%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	EMCORE Reports Fiscal 2023 Fourth Quarter Results 12/12/2023 16:01 ET after hours	Day +1 -22.71% 2023-12-14 Day +5 -20.77% 2023-12-20 Best recovery within 5 -16.73% 2023-12-15 Five sessions later the drop was 3.0% bigger, at -20.77%. Month end -5.51% on 2023-12-29
Close before and after $5.18 to $4.13 as traded Session open, high, low $4.90, $4.90, $3.89 Opening gap -5.31% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 218,935 shares, $904,420 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	MDRX	-20.02%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Veradigm Inc. Announces Leadership Transition 12/08/2023 08:45 ET premarket	Day +1 -19.70% 2023-12-11 Day +5 -23.43% 2023-12-15 Best recovery within 5 -19.70% 2023-12-11 Five sessions later the drop was 17.0% bigger, at -23.43%. Month end -16.68% on 2023-12-29
Close before and after $12.59 to $10.07 split-adjusted Session open, high, low $12.25, $12.25, $9.86 Opening gap -2.70% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 8,746,625 shares, $88,078,514 Relative volume 9.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	MBOT Also on the opposite board this month on both boards	-20.00%	2023-12-29 against the close of 2023-12-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules 12/29/2023 08:00 ET premarket	Day +1 -35.12% 2024-01-02 Day +5 -33.66% 2024-01-08 Best recovery within 5 -29.76% 2024-01-04 Five sessions later the drop was 68.3% bigger, at -33.66%. Month end -20.00% on 2023-12-29 same session This month ended before the fifth session after the move.
Close before and after $2.05 to $1.64 split-adjusted Session open, high, low $1.53, $1.78, $1.52 Opening gap -25.37% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 4,499,449 shares, $7,379,096 Relative volume 82.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	KZIA	-19.56%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Kazia Therapeutics Announces $2 Million Registered Direct Offering 12/01/2023 08:00 ET premarket	Day +1 -20.14% 2023-12-04 Day +5 -28.66% 2023-12-08 Best recovery within 5 -18.03% 2023-12-05 Five sessions later the drop was 46.5% bigger, at -28.66%. Month end -21.62% on 2023-12-29
Close before and after $28.04 to $22.55 split-adjusted Session open, high, low $25.00, $25.00, $22.50 Opening gap -10.83% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 4,044 shares, $91,192 Relative volume 2.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	ATRA	-19.44%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories 12/20/2023 16:01 ET after hours	Day +1 -2.06% 2023-12-22 Day +5 -7.35% 2023-12-29 Best recovery within 5 +1.16% 2023-12-27 62.2% of the drop was recovered five sessions later. Month end -7.35% on 2023-12-29
Close before and after $13.84 to $11.15 split-adjusted Session open, high, low $15.50, $17.25, $11.06 Opening gap +12.01% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 781,453 shares, $8,711,247 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	NXTC	-19.31%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	NextCure Provides Year-End Clinical Pipeline Updates 12/14/2023 06:45 ET premarket	Day +1 -23.45% 2023-12-15 Day +5 -22.76% 2023-12-21 Best recovery within 5 -18.97% 2023-12-19 Five sessions later the drop was 17.9% bigger, at -22.76%. Month end -21.38% on 2023-12-29
Close before and after $17.40 to $14.04 split-adjusted Session open, high, low $12.84, $14.28, $12.36 Opening gap -26.21% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 98,843 shares, $1,387,756 Relative volume 26.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	PWM	-18.96%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Prestige Wealth Inc. Announces First Half of Fiscal Year 2023 Financial Results 12/01/2023 16:30 ET after hours	Day +1 +1.90% 2023-12-05 Day +5 +14.22% 2023-12-11 Best recovery within 5 +14.22% 2023-12-11 It recovered the whole drop and closed 14.22% above the pre-news price. Month end -0.47% on 2023-12-29
Close before and after $2.11 to $1.71 as traded Session open, high, low $2.14, $2.25, $1.56 Opening gap +1.42% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 162,830 shares, $278,439 Relative volume 4.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
96	IOVA	-18.67%	2023-12-27 against the close of 2023-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer 12/27/2023 07:00 ET premarket	Day +1 -3.49% 2023-12-28 Day +5 -8.77% 2024-01-04 Best recovery within 5 -3.49% 2023-12-28 53.0% of the drop was recovered five sessions later. Month end -8.55% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $8.89 to $7.23 split-adjusted Session open, high, low $7.06, $7.37, $6.70 Opening gap -20.58% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 31,298,339 shares, $226,286,991 Relative volume 5.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
97	BMEA More than one ranked move this month 2+ ranked moves	-18.54%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Biomea Fusion to Present Long-Term Follow-Up Data from Ongoing Phase II Study (COVALENT-111) of BMF-219 in Adults with Type 2 Diabetes and Results from Ex-Vivo Human Islet Experiments at the World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) 12/07/2023 09:15 ET premarket	Day +1 -8.46% 2023-12-08 Day +5 -23.85% 2023-12-14 Best recovery within 5 -8.46% 2023-12-08 Five sessions later the drop was 28.6% bigger, at -23.85%. Month end -21.30% on 2023-12-29
Close before and after $18.45 to $15.03 split-adjusted Session open, high, low $18.45, $20.46, $14.62 Opening gap 0.00% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 3,768,600 shares, $56,642,058 Relative volume 8.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
98	APDN under $25M today	-18.43%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results 12/07/2023 16:05 ET after hours	Day +1 -30.09% 2023-12-11 Day +5 -42.50% 2023-12-15 Best recovery within 5 -29.63% 2023-12-13 Five sessions later the drop was 130.6% bigger, at -42.50%. Month end -42.89% on 2023-12-29
Close before and after $1,080.00 to $881.00 as traded Session open, high, low $970.00, $1,000.00, $881.00 Opening gap -10.19% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 159 shares, $140,079 Relative volume 6.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
99	AAGR under $25M today	-18.28%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	African Agriculture Inc. Holdings Welcomes Mr. Osman Ahmed, Managing Director and Head of Private Equity at 10X Capital, to its Board of Directors 12/18/2023 08:30 ET premarket	Day +1 +28.76% 2023-12-19 Day +5 +104.01% 2023-12-26 Best recovery within 5 +104.01% 2023-12-26 It recovered the whole drop and closed 104.01% above the pre-news price. Month end +109.03% on 2023-12-29
Close before and after $0.5980 to $0.4887 split-adjusted Session open, high, low $0.5720, $0.5830, $0.4560 Opening gap -4.35% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 819,947 shares, $400,708 Relative volume 30.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
100	VLD under $25M today More than one ranked move this month 2+ ranked moves	-18.10%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Velo3D Announces Leadership Transition and Commencement of Strategic Business Review 12/15/2023 08:00 ET premarket	Day +1 -23.17% 2023-12-18 Day +5 -16.67% 2023-12-22 Best recovery within 5 -16.67% 2023-12-22 7.9% of the drop was recovered five sessions later. Month end -42.38% on 2023-12-29
Close before and after $24.15 to $19.78 as traded Session open, high, low $25.75, $25.90, $19.29 Opening gap +6.61% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 248,549 shares, $4,915,926 Relative volume 3.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 238 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

7 candidate events for this board could not be anchored to a trading session and are not listed.

2 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

1 event was left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

10 events were left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

1 event was left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2023, the median decliner was 9.8% deeper below its pre-news close five sessions later; the largest catalyst group was Offering / Dilution, 26 of the 100 events, at a median of -33.8%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still below the pre-news close at day +5
Offering / Dilution	26	26.0%	-33.8%	-44.8%	100.0% of 26
Clinical Trial Results	20	20.0%	-30.4%	-32.6%	100.0% of 20
Other Announcement	17	17.0%	-26.5%	-29.9%	100.0% of 17
Earnings	13	13.0%	-22.2%	-31.3%	92.3% of 13
FDA & Regulatory	5	5.0%	Fewer than 10 events in this group, so no figures are shown.

7 other catalyst types, 19 events: Contract / Partnership, Leadership Change, Reverse Merger / Shell, Uplisting / Compliance, M&A / Acquisition, Crypto & Treasury, Buyback / Dividend.

How much of the drop held

Horizon	Still below the pre-news close close to close	Median change since the measured close as a share of the drop
Day +1	98.0% of 98	2.4% deeper below baseline, of 98
Day +5	98.0% of 98	9.8% deeper below baseline, of 98
Month end	92.5% of 93	3.2% deeper below baseline, of 93
Month end falls before day +5 for 12 of these 93 events, so this row is not a later horizon than the one above it. 93 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2023

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Largest drop
BLUE	3Offering / Dilution, FDA & Regulatory	-45.68%
TRKA	2Other Announcement, Uplisting / Compliance	-71.85%
GGE	2Offering / Dilution	-44.08%
VLD	2Offering / Dilution, Leadership Change	-33.67%
MLGO	2Crypto & Treasury	-30.67%
BMEA	2Clinical Trial Results	-30.31%
PCSA	2FDA & Regulatory, Clinical Trial Results	-25.40%
VAPO	2Other Announcement	-23.86%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Largest drop
VTYX	2023-11, 2023-10	-80.62%
LICY	2023-11, 2023-10	-55.12%
RNLX	2023-11, 2023-09	-37.51%
SLRN	2023-11, 2023-09	-54.12%
LQR	2023-11, 2023-10	-27.83%
PSTV	2023-11, 2023-09	-53.54%
FEMY	2023-10, 2023-09	-35.99%
FFIE	2023-10, 2023-09	-44.31%
CNXA	2023-10, 2023-09	-27.33%
HARP	2023-10, 2023-09	-23.26%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

Industry

20 other industries, 25 events

Industry not known: 30.0%

9 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against November 2023

100 events in the comparable window.

November 2023 median -35.1%, selected from the 11,063 events in that month's eligible pool

December 2023 median -28.8%, 6.3 points shallower than November 2023. December 2023's median is taken over the 100 ranked rows, selected from the 6,174 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.